Background & Aims: Fibrosis, a cardinal feature of a dysfunctional liver, significantly contributes to the ever-increasing mortality due to end-stage chronic liver diseases. The cross-talk, between hepatocytes and hepatic stellate cells, is suggested to play a key role in fibrosis progression. While ample efforts have been devoted to elucidate hepatic stellate cells' functions during liver fibrosis, the regulatory functions of hepatocytes remain elusive. Methods: Using an unbiased functional microRNA screening, we investigated the ability of hepatocytes to regulate fibrosis by fine-tuning gene expression via microRNA modulation. The in vivo functional analyses were performed by inhibiting microRNA in hepatocytes using adeno-associated virus in carbon-tetrachloride-and 3,5-di diethoxycarbonyl-1,4-dihydrocollidine-induced liver fibrosis. Results: We discovered that blocking microRNA-221-3p function in hepatocytes during chronic liver injury facilitates recovery of the liver and faster resolution of the deposited extracellular matrix. Further, we demonstrate that reduced secretion of CC motif chemokine ligand 2, due to post-transcriptional regulation of G protein alpha inhibiting activity polypeptide 2 by microRNA-221-3p, mitigates liver fibrosis. Page%5%of%44% % % Conclusions: Collectively, microRNA modulation in hepatocytes, an easy-to-target cell type in the liver, may serve as a potential therapeutic approach for liver fibrosis.